Raymond James Maintains Outperform on Hologic, Raises Price Target to $88
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Andrew Cooper has maintained an Outperform rating on Hologic (NASDAQ:HOLX) and increased the price target from $85 to $88.
February 02, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has maintained an Outperform rating on Hologic and raised the price target from $85 to $88.
The increase in price target by a reputable analyst firm like Raymond James typically signals a positive outlook on the stock, suggesting potential upside. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100